Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qiagen NV

43.13
+0.93002.20%
Post-market: 43.130.00000.00%16:41 EDT
Volume:1.20M
Turnover:51.98M
Market Cap:9.32B
PE:113.32
High:43.45
Open:43.43
Low:42.85
Close:42.20
Loading ...

Press Release: QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast

Dow Jones
·
15 Jan

Hologic Hits New 52-Week Low: How to Play the Stock Now?

Zacks
·
15 Jan

Qiagen Plans $300 Million Synthetic Share Repurchase

MT Newswires Live
·
13 Jan

Qiagen To Return About $300 Mln To Shareholders Through Synthetic Share Repurchase

Reuters
·
13 Jan

QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase

Business Wire
·
13 Jan

Qiagen Expands QIAcuity Digital PCR System's Capacity

MT Newswires Live
·
10 Jan

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples

Business Wire
·
10 Jan

Qiagen Gets U.S. Clearance for Gastrointestinal-Illness Test

Dow Jones
·
10 Jan

Qiagen Receives FDA Clearance for Gastrointestinal Panel Tests

MT Newswires Live
·
10 Jan

Qiagen Secures U.S. Clearance For First Qiastat-Dx Mini Gastrointestinal Panel To Support Year-Round Outpatient Care

Reuters
·
10 Jan

Qiagen secures U.S. clearance for QIAstat-Dx mini gastrointestinal panel

TIPRANKS
·
10 Jan

QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care

Business Wire
·
10 Jan

QGEN Stock Might Rise Following Partnership With Genomics England

Zacks
·
08 Jan

QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content

Business Wire
·
08 Jan

Morgan Stanley Downgrades QIAGEN to Equalweight From Overweight, Cuts Price Target to $48 From $50

MT Newswires Live
·
06 Jan

Qiagen Nv : Morgan Stanley Cuts to Equal-Weight From Overweight; Cuts Target Price to $48 From $50

THOMSON REUTERS
·
06 Jan

Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?

Insider Monkey
·
31 Dec 2024

New Product Offerings Support QIAGEN's Shares Amid Currency Woes

Zacks
·
30 Dec 2024

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

Zacks
·
30 Dec 2024

With 83% ownership of the shares, Qiagen N.V. (NYSE:QGEN) is heavily dominated by institutional owners

Simply Wall St.
·
25 Dec 2024